US6156527A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Characterizing polypeptides
Assignee: Xzillion GmbH and Co KG
•
Filing: 1998-01-23
•
Granted: 2000-12-05
•
Expires: 2018-01-23
Abstract
Abstract A method for characterizing polypeptides, which comprises: (a) treating a sample comprising a population of one or more polypeptides with a cleavage agent which is known to recognize a specific amino acid residue or sequence in polypeptide chains and to cleave at a cleavage site, whereby the population is cleaved to generate peptide fragments; (b) isolating a population of the peptide fragments which bear at one end a reference terminus comprising either only a C-terminus or only an N-terminus and which bear at the other end the cleavage site proximal to the reference terminus; and c) determining a signature sequence of at least some of the isolated fragments, which signature sequence is the sequence of a predetermined number of amino acid residues running from the cleavage site; wherein the signature sequence and the relative position of the cleavage site to the reference terminus characterize the polypeptide or each polypeptide.
Inventors
- 👤 Gunter Schmidt
- 👤 Andrew Hugin Thompson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 17:46
CPC Classifications
C; C07; C07K; C07K1/00; C07K1/12; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6803; G01N33/6818
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
144 words
A method for characterizing polypeptides, which comprises: (a) treating a sample comprising a population of a plurality of polypeptides with a cleavage agent which is known to recognize in polypeptide chains a specific amino acid residue or sequence and to cleave at a cleavage site, whereby the population is cleaved to generate peptide fragments; (b) isolating a population of peptide fragments which comprises only terminal peptide fragments bearing as a reference terminus the N-terminus or the C-terminus of the polypeptide from which fragments were derived, each peptide fragment bearing at the other end the cleavage site proximal to the reference terminus; and (c) determining by mass spectrometry a signature sequence of at least some of the isolated fragments, which signature sequence is the sequence of a predetermined number of amino acid residues running from the cleavage site; wherein a signature sequence characterize each polypeptide.
Claim 2
Independent Claim
144 words
A method for characterizing polypeptides, which comprises: (a) treating a sample comprising a population of a plurality of polypeptides with a cleavage agent which is known to recognize in polypeptide chains a specific amino acid residue or sequence and to cleave at a cleavage site, whereby the population is cleaved to generate peptide fragments; (b) isolating a population of peptide fragments which comprises only terminal peptide fragments bearing as a reference terminus the N-terminus or the C-terminus of the polypeptide from which fragments were derived, each peptide fragment bearing at the other end the cleavage site proximal to the reference terminus; and (c) determining by mass spectrometry a signature sequence of at least some of the isolated fragments, which signature sequence is the sequence of a predetermined number of amino acid residues running from the cleavage site; wherein a signature sequence characterize each polypeptide.
Claim 3
Dependent Claim
27 words
The method according to claim 1, wherein the reference terminus is attached to a solid phase support to immobilized the population of polypeptides or peptide fragments thereof.
Claim 4
Dependent Claim
19 words
The method according to claim 2, wherein the population of polypeptides is immobilized before treatment with the cleavage agent.
Claim 5
Dependent Claim
94 words
The method according to claim 2 or claim 3, wherein the reference terminus is attached to the solid phase support by: (i) treating the polypeptides with a blocking agent to block all exposed reference groups, which comprise either carboxyl groups or primary amine groups; (ii) cleaving the reference terminal amino acids to expose unblocked reference termini; and iii) treating the unblocked reference termini with an immobilisation agent capable of coupling to the solid phase support; wherein step (b) comprises binding the treated reference termini to the solid phase support and removing unbound peptide fragments.
Claim 6
Dependent Claim
99 words
The method according to claim 1, which further comprises (i) preparing the sample step (a) by pre-treating the polypeptides with a blocking agent to block all exposed reference groups, which comprise either carboxyl groups or primary amine groups, so that subsequent treatment of the sample with the cleavage agent generates peptide fragments bearing unblocked reference termini; (ii) treating the unblocked reference termini with an immobilization agent capable of coupling to a solid phase support; and (iii) binding the peptide fragments containing the unblocked reference termini to the solid phase support; wherein step (b) comprises eluting unbound peptide fragments therefrom.
Claim 7
Dependent Claim
14 words
The method according to claim 4, wherein the immobilization agent comprises a biotinylation agent.
Claim 8
Dependent Claim
12 words
The method according to claim 4, wherein the reference group is carboxyl.
Claim 9
Dependent Claim
13 words
The method according to claim 1, wherein the cleavage agent comprises a peptidase.
Claim 10
Dependent Claim
16 words
The method according to claim 1, wherein the sample of step (a) comprises a sub-cellular fraction.
Claim 11
Dependent Claim
18 words
The method according to claim 1, which further comprises preparing the sample of step (a) by liquid chromatography.
Claim 12
Dependent Claim
24 words
The method according to claim 1, wherein the mass spectrometry is preceded by a high pressure liquid chromatography step to resolve the peptide fragments.
Claim 13
Dependent Claim
19 words
The method according to claim 1, wherein the peptide fragments are subjected to ion exchange chromatography before step (c).
Claim 14
Dependent Claim
19 words
The method according to claim 1, wherein the predetermined number of amino acid residues is from 3 to 30.
Claim 15
Dependent Claim
62 words
A method for identifying polypeptides in a test sample, which comprises characterizing the polypeptides in accordance with a method according to claim 1, comparing the signature sequences and relative positions of the cleavage site obtained thereby with the signature sequences and relative positions of the cleavage site of further polypeptides in order to identify the or each polypeptide in the test sample.
Claim 16
Dependent Claim
60 words
A method for assaying for one or more specific polypeptides in a test sample, which comprises performing a method according to claim 1, wherein the cleavage agent and relative position of the cleavage site is predetermined and the signature sequence is determined in step (c) by assaying for a predetermined sequence of amino acid residues running from the cleavage site.
Claim 17
Dependent Claim
26 words
A method according to claim 15, wherein the cleavage site and signature sequence are predetermined by selecting corresponding sequences from one or more known target polypeptides.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-12-05 | 2004-06-05 | 2004-12-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-12-05 | 2008-06-05 | 2008-12-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-12-05 | 2012-06-05 | 2012-12-05 | $7700.00 | Window Closed / Lapsed |